• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用受限平均生存时间对不同居住区域的医疗保健过程质量指标进行跨部门比较。

Cross-Sectoral Comparisons of Process Quality Indicators of Health Care Across Residential Regions Using Restricted Mean Survival Time.

作者信息

Šinkovec Hana, Gall Walter, Heinze Georg

机构信息

Institute of Clinical Biometrics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.

Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.

出版信息

Med Care. 2024 Nov 1;62(11):748-756. doi: 10.1097/MLR.0000000000002057. Epub 2024 Oct 11.

DOI:10.1097/MLR.0000000000002057
PMID:39733232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11462882/
Abstract

BACKGROUND

Practice guidelines recommend patient management based on scientific evidence. Quality indicators gauge adherence to such recommendations and assess health care quality. They are usually defined as adverse event rates, which may not fully capture guideline adherence over time.

METHODS

For assessing process indicators where compliance to the recommended treatment can be assessed by evaluating a patient's trace in linked routine databases, we propose using restricted mean survival time or restricted mean time lost, which are applicable even in competing risk situations. We demonstrate their application by assessing the compliance of patients with acute myocardial infarction (AMI) to high-power statins over 12 months in Austria's political districts, using pseudo-observations and employing causal inference methods to achieve regional comparability.

RESULTS

We analyzed the compliance of 31,678 AMI patients from Austria's 116 political districts with index AMI between 2011 and 2015. The results revealed considerable compliance variations across districts but also plausible spatial similarities.

CONCLUSIONS

Restricted mean survival time and restricted mean time lost provide interpretable estimates of patients' expected time in compliance (lost), well-suited for risk-adjusted entity comparisons in the presence of (measurable) confounding, censoring, and competing risks.

摘要

背景

实践指南建议依据科学证据进行患者管理。质量指标衡量对这些建议的遵循情况并评估医疗质量。它们通常被定义为不良事件发生率,而这可能无法全面反映长期的指南遵循情况。

方法

为了评估过程指标,在通过评估患者在关联的常规数据库中的轨迹来评估对推荐治疗的依从性时,我们建议使用受限平均生存时间或受限平均失访时间,即使在存在竞争风险的情况下它们也适用。我们通过评估奥地利各行政区急性心肌梗死(AMI)患者在12个月内对高强度他汀类药物的依从性来展示它们的应用,使用虚拟观察值并采用因果推断方法以实现区域可比性。

结果

我们分析了2011年至2015年间奥地利116个行政区中31,678例首次发生AMI的患者的依从性。结果显示各行政区之间存在显著的依从性差异,但也有合理的空间相似性。

结论

受限平均生存时间和受限平均失访时间为患者的预期依从时间(失访时间)提供了可解释的估计值,非常适合在存在(可测量的)混杂、删失和竞争风险的情况下进行风险调整后的实体比较。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/9425e49a6407/mlr-62-748-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/1fec9bc1f059/mlr-62-748-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/c15feec5f208/mlr-62-748-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/86f544c71a06/mlr-62-748-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/9425e49a6407/mlr-62-748-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/1fec9bc1f059/mlr-62-748-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/c15feec5f208/mlr-62-748-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/86f544c71a06/mlr-62-748-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b27/11462882/9425e49a6407/mlr-62-748-g004.jpg

相似文献

1
Cross-Sectoral Comparisons of Process Quality Indicators of Health Care Across Residential Regions Using Restricted Mean Survival Time.使用受限平均生存时间对不同居住区域的医疗保健过程质量指标进行跨部门比较。
Med Care. 2024 Nov 1;62(11):748-756. doi: 10.1097/MLR.0000000000002057. Epub 2024 Oct 11.
2
PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.PCSK9 抑制剂和依折麦布降低心血管事件风险的临床实践指南:基于风险分层的推荐意见。
BMJ. 2022 May 4;377:e069066. doi: 10.1136/bmj-2021-069066.
3
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
4
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.改善消费者安全有效用药的干预措施:系统评价概述
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD007768. doi: 10.1002/14651858.CD007768.pub3.
5
A systematic review and economic evaluation of statins for the prevention of coronary events.他汀类药物预防冠状动脉事件的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(14):1-160, iii-iv. doi: 10.3310/hta11140.
6
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Automated telephone communication systems for preventive healthcare and management of long-term conditions.用于预防性医疗保健和长期病症管理的自动电话通信系统。
Cochrane Database Syst Rev. 2016 Dec 14;12(12):CD009921. doi: 10.1002/14651858.CD009921.pub2.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.

本文引用的文献

1
Doubly-robust estimator of the difference in restricted mean times lost with competing risks data.具有竞争风险数据的受限平均损失时间差的双重稳健估计量。
Stat Methods Med Res. 2022 Oct;31(10):1881-1903. doi: 10.1177/09622802221102625. Epub 2022 May 23.
2
Application of Standardization for Causal Inference in Observational Studies: A Step-by-step Tutorial for Analysis Using R Software.标准化因果推断在观察性研究中的应用:使用 R 软件进行分析的分步教程。
J Prev Med Public Health. 2022 Mar;55(2):116-124. doi: 10.3961/jpmph.21.569. Epub 2022 Feb 11.
3
Analyzing differences between restricted mean survival time curves using pseudo-values.
分析使用伪值的受限平均生存时间曲线之间的差异。
BMC Med Res Methodol. 2022 Mar 18;22(1):71. doi: 10.1186/s12874-022-01559-z.
4
G-computation and doubly robust standardisation for continuous-time data: A comparison with inverse probability weighting.连续时间数据的G计算和双重稳健标准化:与逆概率加权法的比较
Stat Methods Med Res. 2022 Apr;31(4):706-718. doi: 10.1177/09622802211047345. Epub 2021 Dec 3.
5
Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models.在存在竞争风险的情况下,使用灵活参数生存模型估计受限平均生存时间和预期寿命损失。
BMC Med Res Methodol. 2021 Mar 11;21(1):52. doi: 10.1186/s12874-021-01213-0.
6
On the empirical choice of the time window for restricted mean survival time.限制平均生存时间的时间窗口的经验选择。
Biometrics. 2020 Dec;76(4):1157-1166. doi: 10.1111/biom.13237. Epub 2020 Feb 26.
7
Double robust estimation for multiple unordered treatments and clustered observations: Evaluating drug-eluting coronary artery stents.针对多种无序治疗和聚类观察的双重稳健估计:评估药物洗脱冠状动脉支架。
Biometrics. 2019 Mar;75(1):289-296. doi: 10.1111/biom.12927. Epub 2018 Jul 13.
8
On the propensity score weighting analysis with survival outcome: Estimands, estimation, and inference.基于生存结局的倾向评分加权分析:目标值、估计和推断。
Stat Med. 2018 Nov 20;37(26):3745-3763. doi: 10.1002/sim.7839. Epub 2018 May 31.
9
An application of restricted mean survival time in a competing risks setting: comparing time to ART initiation by injection drug use.受限平均生存时间在竞争风险环境下的应用:比较注射吸毒者开始接受抗逆转录病毒治疗的时间。
BMC Med Res Methodol. 2018 Mar 9;18(1):27. doi: 10.1186/s12874-018-0484-z.
10
Causal inference in survival analysis using pseudo-observations.使用伪观测值进行生存分析中的因果推断。
Stat Med. 2017 Jul 30;36(17):2669-2681. doi: 10.1002/sim.7297. Epub 2017 Apr 6.